Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
The mycosis fungoides cutaneous microenvironment shapes dysfunctional cell trafficking, antitumor immunity, matrix interactions, and angiogenesis
Alyxzandria M. Gaydosik, Connor J. Stonesifer, Tracy Tabib, Robert Lafyatis, Larisa J. Geskin, Patrizia Fuschiotti
Alyxzandria M. Gaydosik, Connor J. Stonesifer, Tracy Tabib, Robert Lafyatis, Larisa J. Geskin, Patrizia Fuschiotti
View: Text | PDF
Research Article Dermatology Oncology

The mycosis fungoides cutaneous microenvironment shapes dysfunctional cell trafficking, antitumor immunity, matrix interactions, and angiogenesis

  • Text
  • PDF
Abstract

Malignant T lymphocyte proliferation in mycosis fungoides (MF) is largely restricted to the skin, implying that malignant cells are dependent on their specific cutaneous tumor microenvironment (TME), including interactions with non-malignant immune and stromal cells, cytokines, and other immunomodulatory factors. To explore these interactions, we performed a comprehensive transcriptome analysis of the TME in advanced-stage MF skin tumors by single-cell RNA sequencing. Our analysis identified cell-type compositions, cellular functions, and cell-to-cell interactions in the MF TME that were distinct from those from healthy skin and benign dermatoses. While patterns of gene expression were common among patient samples, high transcriptional diversity was also observed in immune and stromal cells, with dynamic interactions and crosstalk between these cells and malignant T lymphocytes. This heterogeneity mapped to processes such as cell trafficking, matrix interactions, angiogenesis, immune functions, and metabolism that affect cancer cell growth, migration, and invasion, as well as antitumor immunity. By comprehensively characterizing the transcriptomes of immune and stromal cells within the cutaneous microenvironment of individual MF tumors, we have identified patterns of dysfunction common to all tumors that represent a resource for identifying candidates with therapeutic potential as well as patient-specific heterogeneity that has important implications for personalized disease management.

Authors

Alyxzandria M. Gaydosik, Connor J. Stonesifer, Tracy Tabib, Robert Lafyatis, Larisa J. Geskin, Patrizia Fuschiotti

×

Figure 8

T lymphocyte–focused intercellular communication in the TME of advanced MF.

Options: View larger image (or click on image) Download as PowerPoint
T lymphocyte–focused intercellular communication in the TME of advanced ...
Visualization of the T cell interactions with cell of interest (macrophages/DCs, B cells, keratinocytes, fibroblasts, and ECs) in the cutaneous microenvironment of MF and controls. Circos plots of top 10 interactions between ligand cell type and receptor cell type (edges) are shown. (A) Top 10 significant T cell interactions in MF (n = 7), HC (n = 9), AD (n = 4), and PS (n = 4) skin samples combined. (B) Top 10 significant incoming and outgoing interactions between T cells from the malignant expanded clone (clonotype 1) with the cells of interest and benign T cells are depicted. Four independent tumor samples are shown. In A and B, edge thickness is proportional to weight scale, which is larger when an edge is more highly associated with a specific cell type–cell type. Edge color labels the source cell type. In all Circos plots, ligands occupy the lower semicircle and corresponding receptors the upper semicircle, and ligands and receptors are colored by the expressing cell type. In all cases, the network shown has been limited to those edges in which the ligand and receptor are both expressed in more than 10% of their respective clusters and have a P value less than 0.05. The full results of the connectomic analysis can be found in Supplemental Table 6. (C and D) Multicolor immunofluorescence microscopy staining for CD3, ITGB1, and TOX in advanced MF (n = 5), HC (n = 4), AD (n = 3), and PS (n = 3) skin samples (C) and CD3, ITGB1, and TNC (top panels) or CD14 (bottom panels) in advanced MF (n = 5) skin samples (D). Representative examples are shown (×1,000). DAPI stains nuclei.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts